ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 1 filers reported holding ADICET BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223,025 | -44.0% | 162,792 | -0.6% | 0.00% | – |
| Q2 2023 | $397,927 | +72914.1% | 163,756 | +72.9% | 0.00% | – |
| Q1 2023 | $545 | -39.0% | 94,685 | -5.3% | 0.00% | – |
| Q4 2022 | $894 | -99.9% | 100,011 | -11.4% | 0.00% | -100.0% |
| Q3 2022 | $1,605,000 | +3.8% | 112,853 | +6.6% | 0.00% | 0.0% |
| Q2 2022 | $1,546,000 | +25.4% | 105,869 | +29.7% | 0.00% | – |
| Q1 2022 | $1,233,000 | +64.4% | 81,597 | +54.5% | 0.00% | – |
| Q4 2021 | $750,000 | +58.6% | 52,817 | -19.6% | 0.00% | – |
| Q3 2021 | $473,000 | -26.0% | 65,726 | +5.8% | 0.00% | – |
| Q2 2021 | $639,000 | – | 62,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,885,000 | 9.89% |
| Foresite Capital Management V, LLC | 680,000 | $9,928,000 | 6.94% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,482,000 | 6.26% |
| DAFNA Capital Management LLC | 935,766 | $13,662,000 | 3.72% |
| COWEN AND COMPANY, LLC | 2,443,780 | $35,679,000 | 3.45% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,468,000 | 3.21% |
| JOHNSON & JOHNSON | 728,944 | $10,643,000 | 2.72% |
| Cormorant Asset Management, LP | 1,800,000 | $26,280,000 | 1.99% |
| Orbimed Advisors | 7,447,141 | $108,728,000 | 1.97% |
| RTW INVESTMENTS, LP | 3,951,281 | $57,689,000 | 1.49% |